Pyridostigmine

Pyridostigmine bromide is approved for military use only as a pretreatment against the lethal effects of soman nerve agent poisoning. It is always used alongside:

• Protective garments — mask, hood, and overgarments (the primary protection)
• Atropine and pralidoxime (2-PAM) — antidotes given immediately if soman exposure occurs

Soman nerve agent kills by permanently destroying an enzyme called acetylcholinesterase, which the body needs to control nerve-to-muscle signals. Without it, the signaling chemical acetylcholine builds up to dangerous levels, overstimulating breathing muscles, glands, and the brain — leading to respiratory failure and death. Pyridostigmine works by temporarily and reversibly occupying some of those enzyme sites before soman arrives, shielding them from permanent damage.

When pyridostigmine's effect naturally fades, those protected enzyme sites become active again. That small amount of recovered enzyme activity is enough to keep the body functioning — but only if atropine and pralidoxime are given quickly once poisoning signs appear. Pyridostigmine itself is not thought to enter the brain in significant amounts, so its protective effect is mainly in the peripheral (body) nervous system.

Pyridostigmine bromide extended-release tablets are taken once daily by mouth, started at least several hours before any anticipated soman exposure. Food matters significantly — always take it with a medium- or high-fat, medium- or high-calorie meal to maintain effective drug levels throughout the day. Do not take it with a low-fat, low-calorie meal, on an empty stomach, or with alcohol.

• Take well before potential exposure — not at the moment of an alarm
• Stop immediately if any signs of nerve-agent poisoning appear
• Use beyond 14 consecutive days should be re-evaluated based on the real risk of exposure
• Follow all instructions from military medical personnel exactly

Most side effects are related to the drug's effect on the nervous system and are generally mild. Common ones include:

• Diarrhea and abdominal pain or cramps
• Nausea or vomiting
• Muscle twitching (fasciculations) or muscle pain
• Increased urination frequency
• Excessive sweating or saliva
• Increased mucus in the airways
• Dysmenorrhea (menstrual cramps, in those who menstruate)

Seek immediate medical attention for difficulty breathing, severe dizziness, loss of consciousness, or rapidly worsening muscle weakness — these may signal a serious cholinergic reaction or crisis.

• Stop and get antidotes at the first sign of poisoning. At any sign of soman nerve-agent poisoning — including pinpoint pupils, excessive drooling, chest tightness, confusion, or seizures — stop pyridostigmine immediately and receive atropine and pralidoxime right away.
• Do not take after exposure. Taking pyridostigmine at the same time as or after soman exposure can worsen the effects of a non-fatal dose.
• Protective gear is still essential. Pyridostigmine is not a replacement for masks and protective clothing — it is an additional layer of preparation only.
• Cholinergic crisis risk. Too much pyridostigmine can cause a dangerous build-up of nerve-signaling chemicals, leading to escalating muscle weakness, breathing problems, and potentially death. Atropine is used to treat this.
• Pregnancy risk. Animal studies showed fetal harm. Use only when the threat of soman exposure makes it necessary despite the potential risks.
• Higher-risk individuals — those with asthma, COPD, slow heart rate, or heart rhythm problems — should be monitored closely.

Several medications and substances can interact with pyridostigmine and should be used with caution or avoided:

• Mefloquine (antimalarial): Adds to GI side effects like loose stools; may also affect heart rate.
• Anticholinesterase glaucoma eye drops: Combined use can compound side effects, including worsened night vision.
• Opioid/narcotic pain medications: Can worsen pyridostigmine's tendency to slow the heart rate (bradycardia).
• Depolarizing muscle relaxants (e.g., succinylcholine): Pyridostigmine intensifies their effect, increasing the risk of prolonged paralysis during surgery.
• Non-depolarizing muscle relaxants (e.g., pancuronium): Their doses may need to be increased when pyridostigmine has been used.
• Aminoglycoside antibiotics, certain anesthetics, antiarrhythmic drugs: These can interfere with nerve-to-muscle signaling and should be used very cautiously alongside pyridostigmine.
• Alcohol: Do not take pyridostigmine extended-release tablets with alcohol.
• Dexpanthenol (converts to pantothenic acid): May have additive effects with pyridostigmine.

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

• Do not take if you have a mechanical blockage of the intestines or urinary tract.
• Do not take if you are allergic to pyridostigmine or any other anticholinesterase medication.
• Use with caution if you have asthma or COPD — pyridostigmine can trigger airway tightening and excess mucus.
• Use with caution if you have a slow heart rate (bradycardia) or cardiac arrhythmias (irregular heartbeat).
• Use with caution if you take beta-blocker medications.
• Tell your provider if you have a sensitivity to bromide-containing compounds.
• Pregnancy: Animal studies showed embryo and fetal harm. The risk of soman exposure itself must be weighed against potential fetal risk. Do not delay treatment if exposure has occurred.
• Kidney impairment: Increased risk of side effects; kidney function monitoring may be needed.

Taking too much pyridostigmine can cause a cholinergic crisis — a dangerous state of escalating muscle weakness that can stop the breathing muscles and be fatal. Very high doses may also cause agitation, confusion, hallucinations, and abnormal electrolyte (blood salt) levels. If overdose is suspected, stop the medication immediately, ensure the airway is kept open, and seek emergency medical care — treatment includes atropine and, if needed, breathing support.

Pyridostigmine temporarily blocks the enzyme acetylcholinesterase in the peripheral nervous system, preventing it from being permanently destroyed by soman. This preserves a small reservoir of functional enzyme activity. When pyridostigmine's effect wears off, those enzyme sites recover — and that residual enzyme activity is enough to support survival, as long as atropine and pralidoxime are administered promptly after soman exposure. The drug is not thought to cross into the brain in meaningful amounts, so its protective action is focused in the body's peripheral nerves and muscles.

Pyridostigmine bromide is poorly absorbed from the gut — only about 10–20% of an oral dose actually enters the bloodstream. Taking it with food makes a big difference: a high-fat, high-calorie meal can increase overall drug exposure by more than three times compared to taking it on an empty stomach. The extended-release tablet reaches peak levels in the blood roughly 10–16 hours after a dose when taken with food, helping maintain consistent levels across a once-daily dosing schedule. Taking it with only a low-fat, low-calorie meal results in lower drug levels during the second half of the 24-hour dosing window, which is why a medium- or high-fat meal is required.

Store refrigerated between 2°C to 8°C (36°F to 46°F) in carton or foil overwrap to protect from light until the expiration date. refrigerator, store at 20°C to 25°C (68°F to 77°F) in carton or foil overwrap for up to 5 years minus half of the time spent under refrigerated storage…